| |
| |
|
| Insider
Information: |
Stephan Dietrich A |
| Relationship: |
Founder and CEO, Direc... |
| City: |
Pittsburgh |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
174,472 |
|
|
Indirect Shares
|
63,690 |
|
|
| Direct
Value |
$940,404 |
|
|
|
Indirect Value
|
$343,289 |
|
|
| Total
Shares |
238,162 |
|
|
| Total
Value |
$1,283,693 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neubase Therapeutics Ord Shs |
NBSE |
Founder and CEO, Direc... |
2023-08-02 |
174,472 |
2023-08-02 |
63,690 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBSE |
Neubase Therapeutics Ord ... |
Founder and CEO |
• • • |
2023-08-02 |
4 |
OE |
$0.02 |
$2,051 |
D/D |
93,234 |
93,234 |
0 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
CEO and Director |
• • • |
2023-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
153,000 |
153,000 |
0 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
President and CEO |
• • • |
2023-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
655,000 |
1,471,775 |
0 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
CEO |
• • • |
2022-09-28 |
4 |
OE |
$0.00 |
$825 |
D/D |
750,000 |
816,775 |
0 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
President and CEO |
• • • |
2021-12-31 |
4 |
OE |
$0.00 |
$42 |
D/D |
42,250 |
66,775 |
0 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
President and CEO |
• • • |
2021-04-26 |
4 |
B |
$5.00 |
$60,000 |
D/D |
12,000 |
24,525 |
3.23 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
President and CEO |
• • • |
2020-12-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,547,639 |
1,273,819 |
0 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
President and CEO |
• • • |
2020-11-30 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,273,819 |
2,547,639 |
0 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
President and CEO |
• • • |
2020-11-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,547,639 |
2,547,639 |
0 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
President and CEO |
• • • |
2019-07-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,547,639 |
2,547,639 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
